StockData
Evolent Health, Inc. logo

Evolent Health, Inc. (EVH) stock

EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3055% below fair value
$3.93−0.69 (-14.94%)

Close on Nov 18, 2026Market cap $444.32MP/E –Yield –

Evolent Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Evolent Health's revenue for the twelve months ending Jun 30, 2026 was $2.10B, down 4.5% year over year. For fiscal 2025 it was $1.88B, down 26.6% from the year before. Over ten years it grew 34.5% a year on average. The highest annual figure on record is $2.55B in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.88B-26.6%
FY2024Dec 31, 2024$2.55B+30.1%
FY2023Dec 31, 2023$1.96B+45.3%
FY2022Dec 31, 2022$1.35B+48.9%
FY2021Dec 31, 2021$907.96M-1.8%
FY2020Dec 31, 2020$924.64M+34.6%
FY2019Dec 31, 2019$687.12M+9.6%
FY2018Dec 31, 2018$627.06M+44.2%
FY2017Dec 31, 2017$434.95M+71.1%
FY2016Dec 31, 2016$254.19M+162.4%
FY2015Dec 31, 2015$96.88M–
FY2014Dec 31, 2014$0-100.0%
FY2013Dec 31, 2013$25.67M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$652.52M+46.9%
Q1 FY2026Mar 31, 2026$496.25M+2.6%
Q4 FY2025Dec 31, 2025$468.72M-27.5%
Q3 FY2025Sep 30, 2025$479.53M-22.8%
Q2 FY2025Jun 30, 2025$444.33M-31.3%
Q1 FY2025Mar 31, 2025$483.65M-24.4%
Q4 FY2024Dec 31, 2024$646.54M+16.3%
Q3 FY2024Sep 30, 2024$621.40M+21.6%
Q2 FY2024Jun 30, 2024$647.15M+37.9%
Q1 FY2024Mar 31, 2024$639.65M+49.6%
Q4 FY2023Dec 31, 2023$556.06M+45.4%
Q3 FY2023Sep 30, 2023$511.02M+44.9%
Q2 FY2023Jun 30, 2023$469.14M+46.6%
Q1 FY2023Mar 31, 2023$427.69M+44.0%
Q4 FY2022Dec 31, 2022$382.43M+54.0%
Q3 FY2022Sep 30, 2022$352.59M+58.5%
Q2 FY2022Jun 30, 2022$319.94M+44.1%
Q1 FY2022Mar 31, 2022$297.06M+38.1%
Q4 FY2021Dec 31, 2021$248.36M+0.7%
Q3 FY2021Sep 30, 2021$222.47M-7.1%
Q2 FY2021Jun 30, 2021$222.06M+2.2%
Q1 FY2021Mar 31, 2021$215.07M-2.8%
Q4 FY2020Dec 31, 2020$246.54M+4.2%
Q3 FY2020Sep 30, 2020$239.57M+8.8%
Q2 FY2020Jun 30, 2020$217.30M+13.2%
Q1 FY2020Mar 31, 2020$221.23M+11.9%
Q4 FY2019Dec 31, 2019$236.53M+22.5%
Q3 FY2019Sep 30, 2019$220.14M+46.8%
Q2 FY2019Jun 30, 2019$191.96M+33.0%
Q1 FY2019Mar 31, 2019$197.76M+41.5%
Q4 FY2018Dec 31, 2018$193.10M+69.8%
Q3 FY2018Sep 30, 2018$149.95M+39.0%
Q2 FY2018Jun 30, 2018$144.30M+34.8%
Q1 FY2018Mar 31, 2018$139.71M+31.5%
Q4 FY2017Dec 31, 2017$113.73M+29.2%
Q3 FY2017Sep 30, 2017$107.91M+79.2%
Q2 FY2017Jun 30, 2017$107.07M–
Q1 FY2017Mar 31, 2017$106.24M–
Q4 FY2016Dec 31, 2016$88.01M–
Q3 FY2016Sep 30, 2016$60.21M–

More Evolent Health figures

See a number that looks wrong?